Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia

Tao, Ling, Liu, Hui-Rong, Gao, Erhe, Teng, Zhi-Ping, Lopez, Bernard L., Christopher, Theodore A., Ma, Xin-Liang, Batinic-Haberle, Ines, Willette, Robert N., Ohlstein, Eliot H., Yue, Tian-Li · 2003 · Circulation

Abstract

Background— Peroxisome proliferator–activated receptor (PPAR) signaling pathways have been reported to exert anti-inflammatory effects and attenuate atherosclerosis formation. However, the mechanisms responsible for their anti-inflammatory and antiatherosclerotic effects remain largely unknown. The present study tested the hypothesis that a PPARγ agonist may exert significant endothelial protection by antioxidative and antinitrative effects. Methods and Results— Male New Zealand White rabbits were randomized to receive a normal (control) or a high-cholesterol diet and treated with vehicle or rosiglitazone (a PPARγ agonist) 3 mg · kg −1 · d −1 for 5 weeks beginning 3 weeks after the high-cholesterol diet. At the end of 8 weeks of a high-cholesterol diet, the rabbits were killed, and the carotid arteries were isolated. Bioactive nitric oxide was determined functionally (endothelium-dependent vasodilatation) and biochemically (the phosphorylation of vasodilator-stimulated phosphoprotein, or P-VASP). Vascular superoxide production, PPARγ, gp91 phox , and inducible nitric oxide synthase (iNOS) expression, and vascular ONOO − formation were determined. Hypercholesterolemia caused severe endothelial dysfunction and reduced P-VASP, despite a marked increase in iNOS expression and total NO x production. Treatment with rosiglitazone enhanced PPARγ expression, improved endothelium-dependent vasodilatation, preserved P-VASP, suppressed gp91 phox and iNOS expression, reduced superoxide and total NO x production, and inhibited nitrotyrosine formation. Conclusions— The PPARγ agonist rosiglitazone exerted a significant vascular protective effect in hypercholesterolemic rabbits, most likely by attenuation of oxidative and nitrative stresses. The endothelial protective effects of PPARγ agonists may reduce leukocyte accumulation in vascular walls and contribute to their antiatherosclerotic effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000097003.49585.5e

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 160

Metadata

Authors
Tao, L., Liu, H.-R., Gao, E., Teng, Z.-P., Lopez, B. L., Christopher, T. A., Ma, X.-L., Batinic-Haberle, I., Willette, R. N., Ohlstein, E. H., & Yue, T.-L.
Venue
Circulation
Published
2003-12-02
Volume
108
Issue
22
Pages
2805-2811
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2162159944
Cited by
160
References
2
FWCI
4.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia. https://app.cochat.ai/papers/10.1161/01.cir.0000097003.49585.5e
The paper
Tao, L., Liu, H.-R., Gao, E., Teng, Z.-P., Lopez, B. L., Christopher, T. A., Ma, X.-L., Batinic-Haberle, I., Willette, R. N., Ohlstein, E. H., & Yue, T.-L. (2003). Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia. Circulation. https://doi.org/10.1161/01.cir.0000097003.49585.5e

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.